Clinical Trials Browser

Phase 2 × Advanced Non-small Cell Lung Cancer (NSCLC) × efatutazone × Clear all

NCT01101334 2020-06-16

Study of Erlotinib With or Without Investigational Drug (CS-7017) in Subjects With Advanced Non-small Cell Lung Cancer

Phase 2 Completed

90 enrolled 11 charts

Advanced Non-small Cell Lung Cancer (NSCLC)